Fig. 2From: The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell/Histiocyte-Rich large B-Cell lymphoma A) NLPHL, H&E(x400); B) Hetrogenous expression of IMP3 in NLPHL, IHC; C) THRLBCL, H&E(x400); D) Strong IMP3 immunoreactivity in THRLBCLBack to article page